Thus, tumour cells that are resistant to caspase-mediated cell death, including GBMs that overexpress Bcl-2, might be more sensitive to granzyme A. IFNγ has also previously been implicated in the modulation of levels of HLA ligands [50]. This evidence concerns the gene BCL2 and neoplasm.